Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Antiviral research, 2022-02, Vol.198, p.105252 [Peer Reviewed Journal]Copyright © 2022 KU Leuven. Published by Elsevier B.V. All rights reserved. ;EISSN: 1872-9096 ;DOI: 10.1016/j.antiviral.2022.105252 ;PMID: 35085683
Digital Resources/Online E-Resources
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||